Multi-institutional trial explores new lifeline for advanced prostate patients
For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are limited…
New research reassures mothers on NSAID safety during the first trimester
Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, taken during the first trimester of pregnancy are not…
Researchers develop pH and redox-sensitive systems to reduce immunotherapy toxicity
Although cancer immunotherapy has transformed treatment by harnessing the immune system to eliminate tumors, only a small subset…
Identifying the methodology gap that prevents treatment of infection-triggered chronic diseases
Thousands of Americans develop chronic persistent symptoms-such as fatigue, cognitive difficulties (“brain fog”), and other debilitating issues-each year…
Your Doctor Is Most Likely Consulting This Free AI Chatbot, Report Says
How would you like it if, when stumped or just in need of some help with an unfamiliar…
Base editing approach repairs deadly Dravet syndrome mutation in mice
Gene editing can repair a DNA error in mice that causes Dravet syndrome, a rare, incurable, and potentially…
Next-generation cancer therapy shows early promise as treatment candidate for glioblastoma
A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for glioblastoma, the most aggressive…
Adult weight gain strongly linked to higher obesity-related cancer risk
New research presented at this year’s European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows…
EFSA gives positive safety opinion on NMN
EFSA considers a daily intake of 300 mg of NMN to be safe for the general population, excluding…
Health panel approves coverage for iPS cell-derived Parkinson’s disease treatment
An advisory panel to the health minister on Wednesday approved Sumitomo Pharma’s Parkinson’s disease treatment Amchepry, which costs…
Perimenopausal women face higher risk of low heart health
Perimenopausal women were two times more likely to have a low cardiovascular health score compared to women having…
Brain controlled hearing technology helps people isolate voices in crowds
Scientists at Columbia University’s Zuckerman Institute have the first direct evidence from human studies that brain-controlled hearing technology…